Literature DB >> 8018021

Sexual function in women with hypothalamo-pituitary disorders.

B Hulter1, P O Lundberg.   

Abstract

The extent to which hypothalamo-pituitary disorders in women affect sexual desire and sexual functions was investigated. Sexual functions and sexual appreciation were assessed in a comprehensive interview of 48 women with well-defined hypothalamo-pituitary disorders. Data about sex life were correlated to blood hormone levels and diagnosis. In most of the women (64.8%), the first clinical symptom indicating a hypothalamo-pituitary dysfunction began in the age group 16 to 35. In 43 patients (89.6%), the initial symptom was menstrual irregularities. Altogether 45 (93.8%) of the women declared that they had or had had significant sexual problems. Two of the three women who did not report sexual problems had never had intercourse. Thirty-eight (79.2%) of the women had developed a lack of or a considerable decrease in sexual desire. Problems with lubrication or orgasm were reported by 31 (64.6%) and 33 (68.7%) of the women, respectively. Normal menstrual pattern, young age, and intrasellar tumor growth correlated better with normal sexual desire and sexual functions than did normal prolactin levels and normal testosterone levels. However, at the time of interview, only 7 women had hyperprolactinemia. Serum testosterone values correlated significantly only with masturbation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8018021     DOI: 10.1007/bf01542097

Source DB:  PubMed          Journal:  Arch Sex Behav        ISSN: 0004-0002


  24 in total

1.  Follow-up studies on 105 cases of verified chromophobe and acidophile pituitary adenomata after treatment by transfrontal operation and x-ray irradiation.

Authors:  S B HEIMBACH
Journal:  Acta Neurochir (Wien)       Date:  1959       Impact factor: 2.216

2.  The results of 300 pituitary adenoma operations (Prof. Herbert Olivecrona's series).

Authors:  L BAKAY
Journal:  J Neurosurg       Date:  1950-05       Impact factor: 5.115

3.  Prolactin-screening tumors and hypogonadism in 22 men.

Authors:  J N Carter; J E Tyson; G Tolis; S Van Vliet; C Faiman; H G Friesen
Journal:  N Engl J Med       Date:  1978-10-19       Impact factor: 91.245

4.  On chromophobe pituitary adenoma. A review of 131 cases.

Authors:  E Fürst
Journal:  Acta Med Scand Suppl       Date:  1966

5.  Mood, sexuality, hormones, and the menstrual cycle. III. Sexuality and the role of androgens.

Authors:  J Bancroft; D Sanders; D Davidson; P Warner
Journal:  Psychosom Med       Date:  1983-12       Impact factor: 4.312

6.  Psychoendocrinology of the menstrual cycle: II. The relationship between enjoyment of activities, moods, and reproductive hormones.

Authors:  J M Abplanalp; R M Rose; A F Donnelly; L Livingston-Vaughan
Journal:  Psychosom Med       Date:  1979-12       Impact factor: 4.312

7.  Androgen levels and sex functions in testosterone-treated hypogonadal men.

Authors:  L J Gooren
Journal:  Arch Sex Behav       Date:  1987-12

8.  Sexual behavior and steroid levels among gynecologically mature premenopausal women.

Authors:  W B Cutler; C R Garcia; G R Huggins; G Preti
Journal:  Fertil Steril       Date:  1986-04       Impact factor: 7.329

9.  Reduction of distress in hyperprolactinemia with bromocriptine.

Authors:  M T Buckman; R Kellner
Journal:  Am J Psychiatry       Date:  1985-02       Impact factor: 18.112

10.  The relationship between plasma prolactin and testosterone levels in male hypogonadism.

Authors:  L J Hipkin; M J Diver; J C Davis
Journal:  J Endocrinol Invest       Date:  1986-12       Impact factor: 4.256

View more
  2 in total

Review 1.  Neurogenic female sexual dysfunction: a review.

Authors:  M L Sipski; A Behnegar
Journal:  Clin Auton Res       Date:  2001-10       Impact factor: 4.435

2.  Masturbation frequency and sexual function domains are associated with serum reproductive hormone levels across the menopausal transition.

Authors:  John F Randolph; Huiyong Zheng; Nancy E Avis; Gail A Greendale; Siobán D Harlow
Journal:  J Clin Endocrinol Metab       Date:  2015-01       Impact factor: 5.958

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.